For more than a decade, researchers have been developing vaccines that use messenger RNA (mRNA) to treat cancer, though none have been approved by the U.S. Food and Drug Administration (FDA), wrote Edward Winstead.
On April 26, 2023, the U.S. National Cancer Institute published an article that confirmed a few studies had compared mRNA cancer vaccine candidates using different technologies.
Read More
